We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:SCNI

Scinai Immunotherapeutics Ltd. (SCNI)

Nasdaq • SCNI • US09073Q4029

Reverse split 19 Nov · 1:4

0.509Last close

Market Closed

Reverse split 19 Nov · 1:4

Trading Signals

ORTEX Data Highlights

As of Oct 28, 2026, ORTEX estimated 0.9% of free float sold short, 0 days to cover, cost to borrow 332.52%. Sign up for live short interest data.

Market Cap

689k USD | # 13569 in US

Volume

2.12m shares | 3.2m USD

Shares Outstanding

4.75m

Free Float Shares

98.29% | 4.67m

News

SCNI key data

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has a market capitalization of $688.79K. Last close $0.51 (as of 2026-11-12); 52-week range $0.39 to $13.00. ORTEX data as of 2026-10-28: short interest was 0.89% of free float, 0 days to cover and the average cost to borrow was 332.52%. Sign up for live short interest data.

SCNI news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.